Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
43
EGBN Quote, Financials, Valuation and Earnings
Last price:
$27.18
Seasonality move
:
-1.84%
Day range:
$27.11 - $27.66
52-week range:
$15.03 - $29.26
Dividend yield:
1.29%
P/E ratio:
7.56x
P/S ratio:
1.31x
P/B ratio:
0.72x
Volume:
290.3K
Avg. volume:
421.2K
1-year change:
4.01%
Market cap:
$826.4M
Revenue:
$634.3M
EPS (TTM):
-$4.22
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $401.4M | $444.8M | $644.3M | $705.6M | $634.3M | |
| Revenue Growth (YoY) | -6.7% | 10.79% | 44.85% | 9.52% | -10.11% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $3M | -$169K | -$11K | $14K | -- | |
| Operating Expenses | -$237.7M | -$189.7M | -$127.5M | -$73.9M | $186.2M | |
| Operating Income | $237.7M | $189.7M | $127.5M | $73.9M | -$186.2M | |
| Net Interest Expenses | $12.2M | $8.1M | $76M | $77.2M | -- | |
| EBT. Incl. Unusual Items | $237.7M | $189.7M | $127.5M | -$30.2M | -$186.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $61M | $48.8M | $27M | $16.8M | -$58.1M | |
| Net Income to Company | $176.7M | $140.9M | $100.5M | -$47M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $176.7M | $140.9M | $100.5M | -$47M | -$128.1M | |
| Basic EPS (Cont. Ops) | $5.53 | $4.40 | $3.31 | -$1.56 | -$4.21 | |
| Diluted EPS (Cont. Ops) | $5.52 | $4.39 | $3.31 | -$1.56 | -$4.21 | |
| Weighted Average Basic Share | $31.9M | $32M | $30.3M | $30.2M | -- | |
| Weighted Average Diluted Share | $32M | $32.1M | $30.4M | $30.2M | -- | |
| EBITDA | $283.5M | $284.7M | $465.8M | $371.8M | -- | |
| EBIT | $277.7M | $281.4M | $462.3M | $368.6M | $148.9M | |
| Revenue (Reported) | $401.4M | $444.8M | $644.3M | $705.6M | $634.3M | |
| Operating Income (Reported) | $237.7M | $189.7M | $127.5M | $73.9M | -$186.2M | |
| Operating Income (Adjusted) | $277.7M | $281.4M | $462.3M | $368.6M | $148.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $98.7M | $132.4M | $170.3M | $172.5M | $161.7M | |
| Revenue Growth (YoY) | -5.82% | 34.21% | 28.62% | 1.26% | -6.24% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $906K | $3K | $3K | $4K | -- | |
| Operating Expenses | -$56.5M | -$52.3M | -$23.9M | -$19.8M | -$5M | |
| Operating Income | $56.5M | $52.3M | $23.9M | $19.8M | $5M | |
| Net Interest Expenses | $1.5M | $4M | $15.9M | $14.3M | $2M | |
| EBT. Incl. Unusual Items | $56.5M | $52.3M | $24.9M | $19.8M | $5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14.9M | $10.1M | $4.7M | $4.5M | -$2.6M | |
| Net Income to Company | $41.6M | $42.2M | $20.2M | $15.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $41.6M | $42.2M | $20.2M | $15.3M | $7.6M | |
| Basic EPS (Cont. Ops) | $1.30 | $1.33 | $0.68 | $0.51 | $0.25 | |
| Diluted EPS (Cont. Ops) | $1.30 | $1.32 | $0.67 | $0.50 | $0.25 | |
| Weighted Average Basic Share | $32M | $31.8M | $29.9M | $30.2M | $30.4M | |
| Weighted Average Diluted Share | $32M | $31.9M | $30M | $30.3M | $30.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $64.5M | $95.8M | $119.3M | $117.4M | $86.2M | |
| Revenue (Reported) | $98.7M | $132.4M | $170.3M | $172.5M | $161.7M | |
| Operating Income (Reported) | $56.5M | $52.3M | $23.9M | $19.8M | $5M | |
| Operating Income (Adjusted) | $64.5M | $95.8M | $119.3M | $117.4M | $86.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $401.2M | $445M | $643.3M | $706.2M | $633.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $3M | -$169K | -$11K | $14K | -- | |
| Operating Expenses | -$237.7M | -$189.7M | -$126.5M | -$73.9M | $186.2M | |
| Operating Income | $237.7M | $189.7M | $126.5M | $73.9M | -$186.2M | |
| Net Interest Expenses | $12.2M | $8.1M | $76M | $77.2M | $19.6M | |
| EBT. Incl. Unusual Items | $237.7M | $189.7M | $127.5M | -$30.2M | -$186.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $61M | $48.8M | $27M | $16.8M | -$58.1M | |
| Net Income to Company | $176.7M | $140.9M | $100.5M | -$47M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $176.7M | $140.9M | $100.5M | -$47M | -$128.1M | |
| Basic EPS (Cont. Ops) | $5.53 | $4.41 | $3.31 | -$1.56 | -$4.22 | |
| Diluted EPS (Cont. Ops) | $5.52 | $4.40 | $3.31 | -$1.56 | -$4.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $277.7M | $281.4M | $462.3M | $368.6M | $148.9M | |
| Revenue (Reported) | $401.2M | $445M | $643.3M | $706.2M | $633.4M | |
| Operating Income (Reported) | $237.7M | $189.7M | $126.5M | $73.9M | -$186.2M | |
| Operating Income (Adjusted) | $277.7M | $281.4M | $462.3M | $368.6M | $148.9M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $445M | $643.3M | $706.2M | $633.4M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$169K | -$11K | $14K | -$1.9M | -- | |
| Operating Expenses | -$189.7M | -$126.5M | -$73.9M | $186.2M | -- | |
| Operating Income | $189.7M | $126.5M | $73.9M | -$186.2M | -- | |
| Net Interest Expenses | $8.1M | $76M | $77.2M | $19.6M | -- | |
| EBT. Incl. Unusual Items | $189.7M | $127.5M | -$30.2M | -$186.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $48.8M | $27M | $16.8M | -$58.1M | -- | |
| Net Income to Company | $140.9M | $100.5M | -$47M | -$68.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $140.9M | $100.5M | -$47M | -$128.1M | -- | |
| Basic EPS (Cont. Ops) | $4.41 | $3.31 | -$1.56 | -$4.22 | -- | |
| Diluted EPS (Cont. Ops) | $4.40 | $3.31 | -$1.56 | -$4.22 | -- | |
| Weighted Average Basic Share | $128M | $121.4M | $120.6M | $121.4M | -- | |
| Weighted Average Diluted Share | $128.3M | $121.6M | $120.8M | $121.7M | -- | |
| EBITDA | $68.4M | $97.2M | $104.3M | $91.5M | -- | |
| EBIT | $281.4M | $462.3M | $368.6M | $148.9M | -- | |
| Revenue (Reported) | $445M | $643.3M | $706.2M | $633.4M | -- | |
| Operating Income (Reported) | $189.7M | $126.5M | $73.9M | -$186.2M | -- | |
| Operating Income (Adjusted) | $281.4M | $462.3M | $368.6M | $148.9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $12.9M | $12.7M | $9M | $11.9M | $11.7M | |
| Short Term Investments | $2.6B | $1.6B | $1.5B | $866.1M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.7B | $321.6M | $776.7M | $685.7M | $697.8M | |
| Property Plant And Equipment | $45.1M | $38M | $29.3M | $26.2M | $41.3M | |
| Long-Term Investments | $1.8B | $404.2M | $814.5M | $744.3M | $803M | |
| Goodwill | $104.2M | $104.2M | $104.2M | $104.2M | -- | |
| Other Intangibles | $87K | $65K | $757K | -$104.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $11.9B | $11.2B | $11.7B | $11.1B | $10.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $300M | $975M | $1.4B | $490M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.4B | $5.8B | $3.8B | $4.3B | $2.5B | |
| Long-Term Debt | $99.8M | $91.8M | $1.4B | $94.2M | $111.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.5B | $9.9B | $10.4B | $9.9B | $9.4B | |
| Common Stock | $316K | $310K | $296K | $298K | $300K | |
| Other Common Equity Adj | -$14.2M | -$199.5M | -$162.4M | -$141.5M | -- | |
| Common Equity | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B | |
| Total Liabilities and Equity | $11.9B | $11.2B | $11.7B | $11.1B | $10.5B | |
| Cash and Short Terms | $4.3B | $1.9B | $2.2B | $1.5B | -- | |
| Total Debt | $99.8M | $91.8M | $1.4B | $94.2M | $111.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $12.9M | $12.7M | $9M | $11.9M | $11.7M | |
| Short Term Investments | $2.6B | $1.6B | $1.5B | $866.1M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.7B | $321.6M | $776.7M | $685.7M | $697.8M | |
| Property Plant And Equipment | $45.1M | $38M | $29.3M | $26.2M | $41.3M | |
| Long-Term Investments | $1.8B | $404.2M | $814.5M | $744.3M | $803M | |
| Goodwill | $104.2M | $104.2M | $104.2M | $104.2M | -- | |
| Other Intangibles | $87K | $65K | $757K | -$104.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $11.9B | $11.2B | $11.7B | $11.1B | $10.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $300M | $975M | $1.4B | $490M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.4B | $5.8B | $3.8B | $4.3B | $2.5B | |
| Long-Term Debt | $99.8M | $91.8M | $1.4B | $94.2M | $111.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.5B | $9.9B | $10.4B | $9.9B | $9.4B | |
| Common Stock | $316K | $310K | $296K | $298K | $300K | |
| Other Common Equity Adj | -$14.2M | -$199.5M | -$162.4M | -$141.5M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.4B | $1.2B | $1.3B | $1.2B | $1.1B | |
| Total Liabilities and Equity | $11.9B | $11.2B | $11.7B | $11.1B | $10.5B | |
| Cash and Short Terms | $4.3B | $1.9B | $2.2B | $1.5B | -- | |
| Total Debt | $99.8M | $91.8M | $1.4B | $94.2M | $111.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $132.2M | $176.7M | $140.9M | $100.5M | -$47M | |
| Depreciation & Amoritzation | $4.7M | $5.9M | $3.3M | $3.5M | $3.2M | |
| Stock-Based Compensation | $5.3M | $7.8M | $9.9M | $10M | $9.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $142.5M | $184.5M | $150.7M | $188.5M | $123.8M | |
| Capital Expenditures | $2.9M | $35.3M | $2.1M | $70K | $326K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$567.1M | -$802.9M | -$882.9M | -$90.5M | $310.7M | |
| Dividends Paid (Ex Special Dividend) | $28.3M | $44.7M | $55.8M | $55M | $45.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $50M | -- | -- | -- | $75.8M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $61.4M | $682K | $33.1M | $48M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $2B | $543.6M | -$670.2M | $312.9M | -$523.7M | |
| Beginning Cash (CF) | $242M | $1.8B | $1.7B | $311.9M | $722.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.5B | -$74.8M | -$1.4B | $410.8M | -$89.2M | |
| Ending Cash (CF) | $1.8B | $1.7B | $311.9M | $722.7M | $633.5M | |
| Levered Free Cash Flow | $139.6M | $149.2M | $148.6M | $188.4M | $123.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.6M | $42.2M | $20.2M | $15.3M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $2M | $2.3M | $2.4M | $2.5M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $6.5M | $52.1M | $56.6M | $10.1M | -- | |
| Capital Expenditures | $30.3M | $595K | -$228K | $143K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$260.8M | -$14.6M | $176.4M | -- | |
| Dividends Paid (Ex Special Dividend) | $12.8M | $14.2M | $14.2M | $5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -$215M | -- | -- | -- | |
| Long-Term Debt Repaid | $200M | -- | -- | -- | -- | |
| Repurchase of Common Stock | $5K | $33.1M | -$2K | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $293.9M | $376.4M | $422.6M | -$163.5M | -- | |
| Beginning Cash (CF) | $2.5B | $144.2M | $258.1M | $610.5M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$786.3M | $167.7M | $464.6M | $23M | -- | |
| Ending Cash (CF) | $1.7B | $311.9M | $722.7M | $633.5M | -- | |
| Levered Free Cash Flow | -$23.8M | $51.5M | $56.9M | $9.9M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $176.7M | $140.9M | $100.5M | -$47M | -- | |
| Depreciation & Amoritzation | $5.9M | $3.3M | $3.5M | $3.2M | -- | |
| Stock-Based Compensation | $7.8M | $9.9M | $10M | $9.6M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $184.5M | $150.7M | $188.5M | $123.8M | -- | |
| Capital Expenditures | $35.3M | $2.1M | $70K | $326K | $204.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$802.9M | -$882.9M | -$90.5M | $310.7M | -- | |
| Dividends Paid (Ex Special Dividend) | $44.7M | $55.8M | $55M | $45.6M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $75.8M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $682K | $33.1M | $48M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $543.6M | -$670.2M | $312.9M | -$523.7M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$74.8M | -$1.4B | $410.8M | -$89.2M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $149.2M | $148.6M | $188.4M | $123.4M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $140.9M | $100.5M | -$47M | -$68.1M | -- | |
| Depreciation & Amoritzation | $843K | $890K | $786K | $1.6M | -- | |
| Stock-Based Compensation | $9.9M | $10M | $9.6M | $5.2M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $150.7M | $188.5M | $123.8M | $34.4M | -- | |
| Capital Expenditures | $2.1M | $70K | $326K | $204.9M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$882.9M | -$90.5M | $310.7M | $375.7M | -- | |
| Dividends Paid (Ex Special Dividend) | $55.8M | $55M | $45.6M | $15M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $75.8M | -- | -- | |
| Long-Term Debt Repaid | -- | $0 | -- | -$440M | -- | |
| Repurchase of Common Stock | $33.1M | $48M | -- | $1.2M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$670.2M | $312.9M | -$523.7M | -$192.8M | -- | |
| Beginning Cash (CF) | $3B | $930.6M | $2.6B | $1.3B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.4B | $410.8M | -$89.2M | $217.3M | -- | |
| Ending Cash (CF) | $1.6B | $1.3B | $2.5B | $934M | -- | |
| Levered Free Cash Flow | $148.6M | $188.4M | $123.4M | -$170.5M | -- | |
Get EGBN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EGBN
Sector
P/E ratio
7.56x
12.54x
PEG ratio
-0.04x
0.32x
P/B ratio
0.72x
1.15x
Price / LTM sales
1.31x
1.86x
Growth Metrics
EGBN
Sector
Revenue growth
-6.24%
5.54%
Earnings growth
-50.98%
11.36%
Revenue (5-year growth)
8.07%
8.68%
Earnings forecast
-$0.01
$0.64
Profitability
EGBN
Sector
Profitability FY 2025
--
--
Return on invested capital
-8.42%
5.2%
Return on assets
-1.18%
1.03%
Return on equity
-10.81%
9.91%
Earnings Date
Last Earnings Date
Jan
21
Next Earnings Date
Apr
22
Estimated Next Earnings Date
Apr
22
Balance Sheet
EGBN
Sector
Total cash
$1.4B
$407.2M
Short term investments
$866.1M
$192.4M
Total assets
$10.5B
$3.1B
Long term debt
$111.7M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
